Current Report Filing (8-k)
October 19 2016 - 9:39AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) October 17, 2016
MEDIFIRST
SOLUTIONS, INC
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-55465
|
|
27-3888260
|
(State
or other
|
|
(Commission
File Number)
|
|
(IRS
Employer
|
jurisdiction
incorporation)
|
|
|
|
Identification
No.)
|
4400 Route 9 South, Suite 1000, Freehold, NJ
|
|
07728
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant's
telephone number, including area code: (732)-786-8044
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item
7.01
|
Regulation FD Disclosure
|
On
October 17, 2016, Medifirst Solutions, Inc. (the “Company”) issued a press release announcing updates regarding its
operations and preparations towards future sales.
A
copy of the press release is attached herewith as Exhibit 99.1.
The
information in this Item 7.01 disclosure, including Exhibit 99.1, is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject
to the liabilities under that Section. In addition, the information in this Item 7.01 disclosure, including Exhibits 99.1, shall
not be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange
Act, except as shall be expressly set forth by specific reference in such filing.
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press
Release dated October 17, 2016
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
MEDIFIRST
SOLUTIONS, INC.
|
|
|
Dated:
October 19, 2016
|
By:
|
/s/
Bruce Schoengood
|
|
|
Bruce
Schoengood
President
and Chief Executive Officer
|
3